Brilliant minds together!

Huge congratulations to my amazing PhD student Cheryl (Xin Ru) Jiang for successfully defending her dissertation! I’m incredibly proud of her hard work and dedication, and I wish her all the very best as she embarks on her next adventure at McKinsey. Congratulations Dr. Jiang!

Outstanding presentation by my colleague and friend Hind Rafei at the #GYNCancerSPORE Conference. She explained complex topics clearly and made the session engaging and informative. A valuable contribution to the field! #NK cell #immunotherapy Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center National Cancer Institute

What an amazing talk by the one and only Rafet on the next generation CARNK for ovarian cancer at the GYN Ca SPORE at the NCI! So many brilliant ideas in the pipeline for solid cancers! MD Anderson Cancer Center Katy Rezvani, M.D., Ph.D National Cancer Institute

Unleashing the Power of NK Cells: From Biological Insights to Therapeutic Frontiers— Katy Rezvani will address this topic in an AACR Education Session at the International Conference on Frontiers in Cancer Science (November 13-15, Singapore). nus.edu/3YsElVQ Katy Rezvani, M.D., Ph.D

Immensely proud to celebrate Kevin Yu-Sung(Kevin) Hsu as our newly coated PhD student! It has been a pleasure to mentor you together with Katy Rezvani, M.D., Ph.D! Your passion and talent will undoubtedly make a significant impact in the field! Here’s to your bright future ahead! GSBS Immunology Program

Kevin / Yu-Sung(Kevin) Hsu, we’re all very excited to see what the future holds - you have so much talent and promise, and our patients will undoubtedly benefit from the translation of your discoveries. Looking forward to co-mentoring you with Hind Rafei. And that white coat suits you

Heartfelt congratulations to Katy Rezvani, M.D., Ph.D !What an incredible day and an exciting future ahead. I feel so fortunate to be part of your team and proud to follow such an inspiring leader!”

Thank you, Dr. Pisters for your inspiring vision. Our team of dedicated scientists and clinicians is committed to advancing cell therapies that will bring transformative treatments to patients with cancer, autoimmune disorders and infection diseases MD Anderson Cancer Center #CellTherapy

Please check out our recent “In a Nutshell” article for brief updates on CAR-NK cell therapy for cancer. Lots of new exciting frontiers in the field! ⁦Katy Rezvani, M.D., Ph.D⁩ ⁦MD Anderson Cancer Center⁩ ⁦British Journal of Haematology⁩ #CARNK #NK #Cell therapy. onlinelibrary.wiley.com/doi/abs/10.111…

Excited to share insights on our progress in CAR-NK cell therapy for cancer in this exciting plenary session AACR special conference on Translating Targeted Therapies in Combination with Radiotherapy in San Diego MD Anderson Cancer Center

Congrats! Rafet ! Keep up the good work.

Thank you Dr. Pisters - it was an honor to share the progress being made at the Institute for Cell Therapy Discovery & Innovation! Very grateful to Greater Houston Partnership for the opportunity to showcase our efforts to bring transformative cell therapies to patients. Looking forward to

Please check out our paper published in Nature Medicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical

Congrats May Daher, simona colla and everyone involved!

Headed back to HTX from Chicago and this is what I saw at O'Hare Intl. Airport. The most powerful brand in cancer care - the global leader:

Pleased to join the first Institute for Cell Therapy Discovery & Innovation's External Advisory Board meeting. With their support and expertise, MD Anderson Cancer Center is well-positioned to translate scientific breakthroughs into powerful cell-based treatments more efficiently, at lower

Thank you Dr Pisters for attending today’s EAB meeting and for your inspiring vision and steadfast support. Deepest thanks also to our extraordinary EAB members: Drs Carl June, Lewis Lanier, Nicholas Huntington Nicholas Huntington , John DiPersio, Helen Heslop, Keith Sullivan,

Delighted to share our Cancer Cell paper published today, co-authored by Dr. Alexander Biederstädt Alexander Biederstädt, MD and Dr. Rafet Basar Rafet reporting the first genome-wide CRISPR screen in primary cord blood NK and CAR NK cells. We identify key genetic checkpoints including